These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The incidence of infantile hypertrophic pyloric stenosis and its association with folic acid supplementation during pregnancy: A nested case-control study. Rosenthal YS, Chodick G, Grossman Z, Shalev V, Koren G. J Pediatr Surg; 2019 Apr; 54(4):701-706. PubMed ID: 29884554 [Abstract] [Full Text] [Related]
7. Fetal safety of macrolides. Bahat Dinur A, Koren G, Matok I, Wiznitzer A, Uziel E, Gorodischer R, Levy A. Antimicrob Agents Chemother; 2013 Jul; 57(7):3307-11. PubMed ID: 23650169 [Abstract] [Full Text] [Related]
13. Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Sørensen HT, Skriver MV, Pedersen L, Larsen H, Ebbesen F, Schønheyder HC. Scand J Infect Dis; 2003 Jul; 35(2):104-6. PubMed ID: 12693559 [Abstract] [Full Text] [Related]
14. No association between macrolide treatment in infancy and later pyloric stenosis in Sweden. Ludvigsson JF, Lundholm C, Örtqvist AK, Almqvist C. Eur J Epidemiol; 2016 Mar; 31(3):331-2. PubMed ID: 26694588 [No Abstract] [Full Text] [Related]
17. Maternal and pregnancy characteristics and risk of infantile hypertrophic pyloric stenosis. Svenningsson A, Svensson T, Akre O, Nordenskjöld A. J Pediatr Surg; 2014 Aug; 49(8):1226-31. PubMed ID: 25092081 [Abstract] [Full Text] [Related]
18. The difficulty in evaluating all findings in study on use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis. de Vries F. BMJ; 2014 Aug 19; 349():g5201. PubMed ID: 25138170 [No Abstract] [Full Text] [Related]
19. [Conservative treatment of hypertrophic pyloric stenosis in children]. Sretenović A, Smoljanić Z, Korać G, Sindjeć S, Lukac M, Krstić Z. Srp Arh Celok Lek; 2004 Oct 19; 132 Suppl 1():93-6. PubMed ID: 15615476 [Abstract] [Full Text] [Related]